| 前收市價 | 0.7000 |
| 開市 | 0.7000 |
| 買盤 | 0.0000 |
| 賣出價 | 0.0000 |
| 拍板 | 2.50 |
| 到期日 | 2024-01-19 |
| 今日波幅 | 0.7000 - 0.7000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 無 |
- Benzinga
Zymergen Highlights Early Results From Work On Potential COVID-19 Drug Candidate
Zymergen Inc (NASDAQ: ZY) announced early results from its work on infectious disease, discovering several potential novel hits against malaria, tuberculosis, and COVID-19 targets. Hits for PfAPP, a critical target in the treatment of malaria, are now being advanced for validation, with hits for an emerging COVID-19 target, PLpro, expected to follow. The multi-target infectious disease program is supported by a Bill & Melinda Gates Foundation grant, enabling Zymergen to identify novel hits for a
- Insider Monkey
10 Best Biotech Stocks Under $20 in Cathie Wood’s Portfolio
In this article, we discuss the 10 best biotech stocks under $20 in Cathie Wood’s portfolio. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Biotech Stocks Under $20 in Cathie Wood’s Portfolio. ARK Investment Management sits on a portfolio value of nearly $42 billion as of Q3, compared […]
- Insider Monkey
Cathie Wood’s Latest Stock Picks Under $10
In this article, we discuss the latest stock picks of Cathie Wood under $10. If you want to skip our detailed analysis of these stocks, go directly to Cathie Wood’s 5 Latest Stock Picks Under $10. The portfolio value of ARK Investment Management, the New York-based hedge fund led by trailblazing investor Cathie Wood, has […]
